AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats
Abstract To provide novel insights into the pathogenesis of heart failure-induced renal dysfunction, we compared the effects of ACE inhibitor (ACEi) and AT1 receptor blocker (ARB) on systemic and kidney hemodynamics during heart failure in normotensive HanSD and hypertensive transgenic (TGR) rats. H...
Guardado en:
Autores principales: | Vojtech Kratky, Zdenka Vanourkova, Matus Sykora, Barbara Szeiffova Bacova, Zdenka Hruskova, Sona Kikerlova, Zuzana Huskova, Libor Kopkan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/268e001c1c7147fca832132a45aab7dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Ahmed Daoud, et al.
Publicado: (2021) -
Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis
por: Jayanthi Peter, et al.
Publicado: (2010) -
Dysregulation of RNF213 promotes cerebral hypoperfusion
por: Takaaki Morimoto, et al.
Publicado: (2018) -
Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker.
por: Xianglin L Du, et al.
Publicado: (2021) -
Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker
por: Xianglin L. Du, et al.
Publicado: (2021)